Francis Medical, Inc.

Francis Medical, Inc. is a privately held medical device company headquartered in Maple Grove, Minnesota. The company's core business is the development of innovative urological cancer treatments, with a mission to provide therapies that are tough on cancer yet gentle on patients through minimally invasive interventions.

The company's primary product is the Vanquish® Water Vapor Ablation System, which utilizes sterile water vapor to ablate cancerous tissue. This technology is designed to minimize damage to surrounding healthy structures, addressing a significant limitation of traditional cancer treatments. While initially focused on prostate cancer, Francis Medical plans to expand its product development to include applications for bladder and kidney cancers.

In December 2025, Francis Medical received FDA 510(k) clearance for the Vanquish® System for prostate tissue ablation. Following this clearance, the company commenced commercial procedures for the Vanquish System across various regions, including the East Coast, Midwest, and Southeast, in early 2026. The company's leadership includes founder and Chief Technology Officer Michael Hoey, and President and CEO Mike Kujak.